OHMX CORPORATION
Arabic-language AI assistant software for control and automation engineers, providing guidance on VFDs, cables, PLCs, and fault diagnosis
- Sector
- Medtech
- Headquarters
- EVANSTON, IL
- Latest Form D
- $3M, Feb 2017
- Total capital
- $16.1M
- Federal grants
- $739K
- 1 award · 2015
- Rank in peer group#15 of 95
- Private capital raised
- $15.4M
- 7 Form D · last Feb 2017
- 116 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 29 pending · first 2015
- Rank in peer group#2 of 95
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$3M
- Federal grantHealth and Human S · Phase II · PSA Peptidase Activity (PPA): A New Biomarker for Prostate Cancer Aggressiveness$739K
- Private capital raisedForm D · SEC · 3rd filing$4M
- Private capital raisedForm D · SEC · 2nd filing$3.4M
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
3 records have no date or no amount, so they aren’t placed on the timeline.
Standing among 95 peers
Line = medianMedtech · Instrument
- Federal grants#15 · top 16%
- Granted patents#2 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Barbara DysonDirectorNamed in SEC Form D filings
- BRIAN DYSONDirectorNamed in SEC Form D filings
- CHARLES BEUG PENNINGTONExecutive Officer, DirectorNamed in SEC Form D filings
- Charles W. RowlandExecutive OfficerNamed in SEC Form D filings
- Gary BlackburnExecutive OfficerNamed in SEC Form D filings
- Geoff McKinleyDirectorNamed in SEC Form D filings
Show all 19 people
- Jeff Beug HawkinsDirectorNamed in SEC Form D filings
- J. Scott HallDirectorNamed in SEC Form D filings
- Jodi Flax-SorianoExecutive OfficerNamed in SEC Form D filings
- Joseph M. DunnDirectorNamed in SEC Form D filings
- Karen L. DysonDirectorNamed in SEC Form D filings
- KIM BEUG ARVANITESDirectorNamed in SEC Form D filings
- Mark Beug MatthewsDirectorNamed in SEC Form D filings
- Michael Beug SeedmanDirectorNamed in SEC Form D filings
- Peter L. DysonDirectorNamed in SEC Form D filings
- Richard Beug ParrilloDirectorNamed in SEC Form D filings
- SCOTT HALLDirectorNamed in SEC Form D filings
- Stuart CornewDirectorNamed in SEC Form D filings
- Thomas Beug MeadeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 36- GrantedBioelectronic Binding Assay Using Peak ProfilingUSPTOUS 9,880,121
- GrantedSingle, Direct Detection Of Hemoglobin A1C Percentage Using Enzyme Triggered Redox Altering Chemical Elimination (e-trace) ImmunoassayUSPTOUS 9,624,522
- PendingElectronic Measurements Of Monolayers Following Homogenous Reactions Of Their ComponentsUSPTOApplication 15194719
Show all 36 patent records
- Bioelectronic Binding Assay Using Peak ProfilingJan 30, 2018 · US 9,880,121Granted
- Single, Direct Detection Of Hemoglobin A1C Percentage Using Enzyme Triggered Redox Altering Chemical Elimination (e-trace) ImmunoassayApr 18, 2017 · US 9,624,522Granted
- Electronic Measurements Of Monolayers Following Homogenous Reactions Of Their ComponentsDec 29, 2016 · Application 15194719Pending
- Electric Measurement Of Monolayers Following Pro-cleave Detection Of Presence And Activity Of Enzymes And Other Target AnalytesAug 16, 2016 · US 9,416,390Granted
- Electronic Measurements Of Monolayers Following Homogeneous Reactions Of Their ComponentsAug 2, 2016 · US 9,404,883Granted
- Enzyme Cascade Methods For E-trace Assay Signal AmplificationJul 14, 2016 · Application 14974736Pending
- Competitive Enzymatic AssayJun 23, 2016 · Application 14975669Pending
- Novel Chemistry Used In BiosensorsMay 17, 2016 · US 9,340,567Granted
- Prostate Specific Antigen Proteolytic Activity For Clinical UseApr 7, 2016 · Application 14863397Pending
- Enzyme Triggered Redox Altering Chemical Elimination (e-trace) Assay With Multiplexing CapabilitiesFeb 11, 2016 · Application 14824045Pending
- Enzyme Cascade Methods For E-trace Assay Signal AmplificationFeb 2, 2016 · US 9,250,203Granted
- Enzyme Triggered Redox Altering Chemical Elimination (E-Trace) ImmunoassayNov 24, 2015 · US 9,194,836Granted
- Novel Chemistry Used In BiosensorsJul 9, 2015 · Application 14593318Pending
- Electrochemical Assay For The Detection Of EnzymesNov 20, 2014 · Application 14281865Pending
- Novel Chemistry Used In BiosensorsOct 23, 2014 · Application 14254817Pending
- Membrane Based Enzyme Triggered Redox Altering Chemical Elimination (e-trace) Assay With Multiplexing Capabilities And Associated CartridgeApplication 62036078Pending
- Bioelectronic Binding Assay On Pre-formed Sams Using Peak ProfilingApplication 61985976Pending
- Bioelectronic Binding Assay Using Peak ProfilingApplication 61985969Pending
- Psa Proteolytic ActivityApplication 62054369Pending
- Electronic Measurements Of Monolayers Following Homogeneous Reactions Of Their ComponentsApplication PCTUS2013052324Pending
- Competitive Enzymatic AssayApplication 62094934Pending
- Electric Measurement Of Monolayers Following Pro-cleave Detection Of Presence And Activity Of Enzymes And Other Target AnalytesApplication PCTUS2013052340Pending
- Bioelectronic Binding Assay Using Peak ProfilingApplication PCTUS2015028316Pending
- Enzyme Triggered Redox Altering Chemical Elimination (-trace) Assay With Multiplexing CapabilitiesApplication PCTUS2015044744Pending
- Enzyme Cascade Methods For E-trace Assay Signal AmplificationApplication PCTUS2013020836Pending
- Prostate Specific Antigen Proteolytic Activity For Clinical UseApplication PCTUS2015051800Pending
- Novel Chemistry Used In BiosensorsApplication PCTUS2012063319Pending
- Competitive Enzymatic AssaysApplication PCTUS2015066705Pending
- Single, Direct Detection Of Hemoglobin A1C Percentage Using Enzyme Triggered Redox Altering Chemical Elimination (e-trace) ImmunoassayApplication PCTUS2012060577Pending
- Biosensor ChipApplication PCTUS2016038186Pending
- PSA Enzymatic Activity: A New Biomarker for Assessing Prostate Cancer AggressivenessApplication 61709680Pending
- Methods For Electronic Signal Amplification Phosphatrace - Procleave Multiplex - AmplificationApplication 61708301Pending
- Novel Chemistry Used In BiosensorsApplication PCTUS2011044689Pending
- Enzyme Triggered Redox Altering Chemical Elimination (e-trace) ImmunoassayApplication PCTUS2010044918Pending
- Electrochemical Assay For The Detection Of EnzymesApplication PCTUS2008080363Pending
- Novel Chemistry Used In BiosensorsApplication PCTUS2008080379Pending
Related companies, and why
- Neuros Medical, Inc.Similar federal contract value in Medtech · null in contracts
- Goodman Consulting Group, LLCSimilar federal contract value in Medtech · null in contracts
- Rani Therapeutics, LLCSimilar federal contract value in Medtech · null in contracts
- Happy Rock Capital, LLCSimilar federal contract value in Medtech · null in contracts
- ASC KIRKLAND LLCSimilar federal contract value in Medtech · null in contracts
- eBeam Film LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .